208 related articles for article (PubMed ID: 28540637)
1. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.
Saito H; Fushida S; Harada S; Miyashita T; Oyama K; Yamaguchi T; Tsukada T; Kinoshita J; Tajima H; Ninomiya I; Ohta T
Gastric Cancer; 2018 Jan; 21(1):55-67. PubMed ID: 28540637
[TBL] [Abstract][Full Text] [Related]
2. The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.
Tsukada T; Fushida S; Harada S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2012 Aug; 41(2):476-82. PubMed ID: 22614335
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.
Shinbo T; Fushida S; Tsukada T; Harada S; Kinoshita J; Oyama K; Okamoto K; Ninomiya I; Takamura H; Kitagawa H; Fujimura T; Yashiro M; Hirakawa K; Ohta T
Oncol Rep; 2015 Feb; 33(2):553-8. PubMed ID: 25435013
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.
Gunjigake K; Kinoshita J; Yamaguchi T; Saito H; Fujimori D; Horiike T; Harada S; Tajima H; Ninomiya I; Ohta T; Fushida S
Gastric Cancer; 2021 Jan; 24(1):31-44. PubMed ID: 32488650
[TBL] [Abstract][Full Text] [Related]
5. Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil.
Kurata T; Fushida S; Kinoshita J; Oyama K; Yamaguchi T; Okazaki M; Miyashita T; Tajima H; Ninomiya I; Ohta T
Cancer Manag Res; 2018; 10():2729-2742. PubMed ID: 30147370
[TBL] [Abstract][Full Text] [Related]
6. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
7. Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells.
Kang SH; Kim SW; Kim KJ; Cho KH; Park JW; Kim CD; Do JY
Kidney Res Clin Pract; 2019 Dec; 38(4):472-480. PubMed ID: 31554027
[TBL] [Abstract][Full Text] [Related]
8. [Role of transforming growth factor-β1 in epithelial-mesenchymal transition of mesothelial cells and its effect on peritoneal metastasis of gastric cancer].
Lyu Z; Kong B; Liu X; Li F; Wang H; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jan; 18(1):54-7. PubMed ID: 25656033
[TBL] [Abstract][Full Text] [Related]
9. Tranilast Inhibits TGF-β1-induced Epithelial-mesenchymal Transition and Invasion/Metastasis
Takahashi K; Menju T; Nishikawa S; Miyata R; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Date H
Anticancer Res; 2020 Jun; 40(6):3287-3296. PubMed ID: 32487624
[TBL] [Abstract][Full Text] [Related]
10. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Cancer Lett; 2014 Dec; 355(1):46-53. PubMed ID: 25224569
[TBL] [Abstract][Full Text] [Related]
12. Tranilast attenuates TGF-β1-induced epithelial-mesenchymal transition in the NRK-52E cells.
Li SS; Liu QF; He AL; Wu FR
Pak J Pharm Sci; 2014 Jan; 27(1):51-5. PubMed ID: 24374452
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.
Miao ZF; Zhao TT; Wang ZN; Miao F; Xu YY; Mao XY; Gao J; Wu JH; Liu XY; You Y; Xu H; Xu HM
Tumour Biol; 2014 Apr; 35(4):3575-83. PubMed ID: 24347485
[TBL] [Abstract][Full Text] [Related]
15. Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer.
Murahashi K; Yashiro M; Inoue T; Nishimura S; Matsuoka T; Sawada T; Sowa M; Hirakawa-Ys Chung K
Int J Oncol; 1998 Dec; 13(6):1235-40. PubMed ID: 9824637
[TBL] [Abstract][Full Text] [Related]
16. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
19. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.
Yin S; Miao Z; Tan Y; Wang P; Xu X; Zhang C; Hou W; Huang J; Xu H
Cancer Med; 2019 Apr; 8(4):1731-1743. PubMed ID: 30791228
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer.
Subramaniam V; Chakrabarti R; Prud'homme GJ; Jothy S
Anticancer Drugs; 2010 Apr; 21(4):351-61. PubMed ID: 20145538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
